- Home
- SENEA vs SRDX Comparison
SENEA vs SRDX Comparison
Compare SENEA & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SENEA
- SRDX
- Stock Information
- Founded
- SENEA 1949
- SRDX 1979
- Country
- SENEA United States
- SRDX United States
- Employees
- SENEA N/A
- SRDX N/A
- Industry
- SENEA Packaged Foods
- SRDX Medical/Dental Instruments
- Sector
- SENEA Consumer Staples
- SRDX Health Care
- Exchange
- SENEA Nasdaq
- SRDX Nasdaq
- Market Cap
- SENEA 505.9M
- SRDX 562.6M
- IPO Year
- SENEA N/A
- SRDX 1998
- Fundamental
- Price
- SENEA $76.47
- SRDX $39.75
- Analyst Decision
- SENEA
- SRDX Hold
- Analyst Count
- SENEA 0
- SRDX 4
- Target Price
- SENEA N/A
- SRDX $43.00
- AVG Volume (30 Days)
- SENEA 21.1K
- SRDX 177.1K
- Earning Date
- SENEA 02-06-2025
- SRDX 01-30-2025
- Dividend Yield
- SENEA N/A
- SRDX N/A
- EPS Growth
- SENEA 23.82
- SRDX N/A
- EPS
- SENEA 5.83
- SRDX N/A
- Revenue
- SENEA $1,482,656,000.00
- SRDX $126,078,000.00
- Revenue This Year
- SENEA N/A
- SRDX $13.75
- Revenue Next Year
- SENEA N/A
- SRDX $13.67
- P/E Ratio
- SENEA $13.12
- SRDX N/A
- Revenue Growth
- SENEA N/A
- SRDX N/A
- 52 Week Low
- SENEA $43.89
- SRDX $25.17
- 52 Week High
- SENEA $80.65
- SRDX $42.44
- Technical
- Relative Strength Index (RSI)
- SENEA 59.80
- SRDX 55.78
- Support Level
- SENEA $71.69
- SRDX $39.50
- Resistance Level
- SENEA $78.79
- SRDX $40.39
- Average True Range (ATR)
- SENEA 2.16
- SRDX 0.38
- MACD
- SENEA -0.00
- SRDX -0.06
- Stochastic Oscillator
- SENEA 53.40
- SRDX 46.67
About SENEA Seneca Foods Corp.
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.
About SRDX Surmodics Inc.
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.